LATEST GROUP NEWS
September 2026:
The National Institutes of Health (NIH - NIAID) has awarded Principal Investigator Professor Paul Carlier and his team $3.76 million grant to develop irresistible blood stage antimalarials.
August 2026:
Congratulations to Dr. Bo Zhou for successfully defending his PhD thesis! We wish him well at The Warren Center for Neuroscience Drug Discovery at Vanderbilt.
Medicinal Chemistry for Global Public Health
Malaria is a scourge in the developing world, affecting 200 million people and killing nearly 450,000 annually. To treat this infected population, new antimalarial drugs are urgently needed. As such, we are taking a two-pronged strategy to reduce malaria transmission and mortality.
(hover with cursor to stop slideshow)
UPCOMING EVENTS
CONTACT
Professor Paul R. Carlier
The Carlier Lab
Office: 551 PHARM